{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:23:35Z","timestamp":1778754215400,"version":"3.51.4"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transfusion\u2010associated graft\u2010versus\u2010host disease (TA\u2010GVHD) is a rare, usually fatal complication of blood transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the characteristics of TA\u2010GVHD in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical records of pediatric patients diagnosed with TA\u2010GVHD between January 2007 and December 2021 were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We analyzed 94 clinical records of pediatric patients (0\u201318\u2009years) with a diagnosis of GVHD, of whom 6 (6.38%) were associated with TA\u2010GVHD; both genders being equally affected. The median age at diagnosis of the underlying disorder was 9\u2009years, 1\u2009month (range 2\u2009months\u201315\u2009years, 3\u2009months); the median age at diagnosis of TA\u2010GVHD was 9\u2009years, 5.5\u2009months (range 1\u2009year, 7\u2009months\u201315\u2009years, 7\u2009months). There were 27 grafts; 8 were irradiated and 12 were filtered. All patients presented with Stage 3 cutaneous TA\u2010GVHD and histopathological Grade 2. All cases corresponded to classic acute TA\u2010GVHD with global clinical Grade I\u2013II. Mortality rate was 67%. The median follow\u2010up of our patients was 2\u2009years and 2\u2009months (range 4\u2009months\u20133\u2009years, 4\u2009months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TA\u2010GVHD, although less frequently encountered than in previous years, is still a concern. Early suspicion of TA\u2010GVHD is mandatory due to its high mortality rates and rapid progression. Prevention by using irradiated blood products is the sole effective measure against this condition. Failing to identify and preempt TA\u2010GVHD not only jeopardizes patient survival but also underscores the critical importance of vigilant monitoring and proactive intervention in at\u2010risk patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/pde.15812","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T22:25:15Z","timestamp":1732487115000},"page":"267-272","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transfusion\u2010Associated Graft\u2010Versus\u2010Host Disease in Pediatric Patients: Clinical Features and Outcomes"],"prefix":"10.1111","volume":"42","author":[{"given":"Isabel","family":"Araiza\u2010Atanacio","sequence":"first","affiliation":[{"name":"Dermatology Department Instituto Nacional de Pediatr\u00eda  Mexico City Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marimar","family":"S\u00e1ez\u2010de\u2010Ocariz","sequence":"additional","affiliation":[{"name":"Dermatology Department Instituto Nacional de Pediatr\u00eda  Mexico City Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-4864","authenticated-orcid":false,"given":"Luz","family":"Orozco\u2010Covarrubias","sequence":"additional","affiliation":[{"name":"Dermatology Department Instituto Nacional de Pediatr\u00eda  Mexico City Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,11,24]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0306-9"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13432"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-620872"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2018.03.002"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0620-RS"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2019.05.014"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12946"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2022.103405"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2005.10.011"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2012.03.010"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12081"},{"issue":"2","key":"e_1_2_9_13_1","first-page":"93","article-title":"El s\u00edndrome de Down \u00bfes una inmunodeficiencia primaria?","volume":"59","author":"G\u00e1mez\u2010Gonz\u00e1lez L. B.","year":"2012","journal-title":"Revista Alergia M\u00e9xico"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.03011.x"},{"issue":"2","key":"e_1_2_9_15_1","first-page":"153","article-title":"Transfusion\u2010Associated Graft\u2010Versus\u2010Host Disease in Severe Combined Immunodeficiency","volume":"20","author":"Sebnem K. S.","year":"2010","journal-title":"Journal of Investigational Allergology and Clinical Immunology"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2008.01073.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2022.103402"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2018.7724"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.16134"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.16945"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.15812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:02:34Z","timestamp":1765533754000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.15812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,24]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1111\/pde.15812"],"URL":"https:\/\/doi.org\/10.1111\/pde.15812","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,24]]},"assertion":[{"value":"2023-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}